These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. Keating NL, O'Malley AJ, Freedland SJ, Smith MR. J Natl Cancer Inst; 2010 Jan 06; 102(1):39-46. PubMed ID: 19996060 [Abstract] [Full Text] [Related]
6. Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Gandaglia G, Sun M, Hu JC, Novara G, Choueiri TK, Nguyen PL, Schiffmann J, Graefen M, Shariat SF, Abdollah F, Briganti A, Montorsi F, Trinh QD, Karakiewicz PI. Eur Urol; 2014 Dec 06; 66(6):1125-32. PubMed ID: 24495466 [Abstract] [Full Text] [Related]
11. Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients. Wu CT, Yang YH, Chen PC, Chen MF, Chen WC. Osteoporos Int; 2015 Sep 06; 26(9):2281-90. PubMed ID: 25990353 [Abstract] [Full Text] [Related]
14. Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists. Bosco C, Wong C, Garmo H, Crawley D, Holmberg L, Hammar N, Adolfsson J, Stattin P, Van Hemelrijck M. BJU Int; 2018 Feb 06; 121(2):260-267. PubMed ID: 28940667 [Abstract] [Full Text] [Related]